Log in to save to my catalogue

Correspondence

Correspondence

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2690926313

Correspondence

About this item

Full title

Correspondence

Publisher

London: Cambridge University Press

Journal title

British journal of psychiatry, 2022-08, Vol.221 (2), p.496-496

Language

English

Formats

Publication information

Publisher

London: Cambridge University Press

More information

Scope and Contents

Contents

Intramuscular forms of haloperidol and olanzapine may have the advantage of being licensed products (although there is no UK-licensed intramuscular olanzapine at the moment), but their use in treatment-resistant patients is ethically unsupportable given the near certainty that they will be ineffective as antipsychotics in this patient group. [...]i...

Alternative Titles

Full title

Correspondence

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2690926313

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2690926313

Other Identifiers

ISSN

0007-1250

E-ISSN

1472-1465

DOI

10.1192/bjp.2021.201

How to access this item